Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Titration of Cytolytic Antitumor Antibody Utilizing Absorbance at 260 m{micro} to Measure the Leakage of Cell Constituents

Titration of Cytolytic Antitumor Antibody Utilizing Absorbance at 260 m{micro} to Measure the... Ehrlich ascites tumor cells were incubated first with rabbit serum and guinea pig complement and then with trypsin to promote leakage of constituents from the damaged cells. The system then was treated with ribonuclease and deoxyribonuclease to free the fibrinous material from the cells by solubilizing it. After the nucleic acids were extracted by the perchloric acid method, absorbance at 260 mµ was measured. Subtraction of results with a given dilution of normal rabbit serum from results with the same dilution of hyperimmune serum permitted evaluation of the cytotoxic activity of the antiserum. Results in tests performed with and without the several enaymes are presented to demonstrate the increase in sensitivity provided by using them. Absorbance data for several rabbit antisera are compared with results in neutralization tests in mice. The titers tend to parallel one another in the two tests. As another example of the use of the cell-leakage test to detect low levels of antibody, measurement of anti-V2x rabbit carcinoma antibody in rabbits bearing the V2x tumor and the alterations in the antibody level during treatment of the rabbits with a vasodilator are presented. A good correlation existed between the level of cell leakage induced by the rabbit serum and regression or lack of regression of the transplanted tumor. 1 Supported in part by USPHS Research Grant No. CA-08061 from the National Cancer Institute and in part by the Michigan State Legislature from an allocation to The University of Michigan Medical School for Cancer Research. 2 Present address: University of Edinburgh, Edinburgh, Scotland. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cancer Research American Association of Cancer Research

Titration of Cytolytic Antitumor Antibody Utilizing Absorbance at 260 m{micro} to Measure the Leakage of Cell Constituents

Titration of Cytolytic Antitumor Antibody Utilizing Absorbance at 260 m{micro} to Measure the Leakage of Cell Constituents

Cancer Research , Volume 29 (6): 1262 – Jun 1, 1969

Abstract

Ehrlich ascites tumor cells were incubated first with rabbit serum and guinea pig complement and then with trypsin to promote leakage of constituents from the damaged cells. The system then was treated with ribonuclease and deoxyribonuclease to free the fibrinous material from the cells by solubilizing it. After the nucleic acids were extracted by the perchloric acid method, absorbance at 260 mµ was measured. Subtraction of results with a given dilution of normal rabbit serum from results with the same dilution of hyperimmune serum permitted evaluation of the cytotoxic activity of the antiserum. Results in tests performed with and without the several enaymes are presented to demonstrate the increase in sensitivity provided by using them. Absorbance data for several rabbit antisera are compared with results in neutralization tests in mice. The titers tend to parallel one another in the two tests. As another example of the use of the cell-leakage test to detect low levels of antibody, measurement of anti-V2x rabbit carcinoma antibody in rabbits bearing the V2x tumor and the alterations in the antibody level during treatment of the rabbits with a vasodilator are presented. A good correlation existed between the level of cell leakage induced by the rabbit serum and regression or lack of regression of the transplanted tumor. 1 Supported in part by USPHS Research Grant No. CA-08061 from the National Cancer Institute and in part by the Michigan State Legislature from an allocation to The University of Michigan Medical School for Cancer Research. 2 Present address: University of Edinburgh, Edinburgh, Scotland.

Loading next page...
 
/lp/american-association-of-cancer-research/titration-of-cytolytic-antitumor-antibody-utilizing-absorbance-at-260-u0FQMRzk68

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Association of Cancer Research
Copyright
Copyright © 1969 by the American Association for Cancer Research.
ISSN
0008-5472
Publisher site

Abstract

Ehrlich ascites tumor cells were incubated first with rabbit serum and guinea pig complement and then with trypsin to promote leakage of constituents from the damaged cells. The system then was treated with ribonuclease and deoxyribonuclease to free the fibrinous material from the cells by solubilizing it. After the nucleic acids were extracted by the perchloric acid method, absorbance at 260 mµ was measured. Subtraction of results with a given dilution of normal rabbit serum from results with the same dilution of hyperimmune serum permitted evaluation of the cytotoxic activity of the antiserum. Results in tests performed with and without the several enaymes are presented to demonstrate the increase in sensitivity provided by using them. Absorbance data for several rabbit antisera are compared with results in neutralization tests in mice. The titers tend to parallel one another in the two tests. As another example of the use of the cell-leakage test to detect low levels of antibody, measurement of anti-V2x rabbit carcinoma antibody in rabbits bearing the V2x tumor and the alterations in the antibody level during treatment of the rabbits with a vasodilator are presented. A good correlation existed between the level of cell leakage induced by the rabbit serum and regression or lack of regression of the transplanted tumor. 1 Supported in part by USPHS Research Grant No. CA-08061 from the National Cancer Institute and in part by the Michigan State Legislature from an allocation to The University of Michigan Medical School for Cancer Research. 2 Present address: University of Edinburgh, Edinburgh, Scotland.

Journal

Cancer ResearchAmerican Association of Cancer Research

Published: Jun 1, 1969

There are no references for this article.